Abbott is voluntarily recalling several of its ready-to-use liquid Similacs infant products due to a bottle defect.
The Food and drug administration announced the recall on Friday, saying certain lots of Abbott’s liquid baby formula are being recalled because less than 1% of the bottles “may not have been completely sealed” which “could lead to spoilage.”
According to the FDA, the affected products are: Similac® Pro-Total ComfortTM, Similac® 360 Total Care®, Similac 360 Total Care Sensitive, Similac® Special Care® 24, Similac Stage 1, Similac® NeoSure®, Similac Water (Sterilized ) and Pedialyte electrolyte solution.
If consumed, individuals may experience “gastrointestinal symptoms such as diarrhea and vomiting.”
Several batch numbers for the affected products are subject to recall and were manufactured at the Company’s facility in Columbus, Ohio.
The FDA says the recall is not expected to affect “the overall supply of infant formula in the United States” and said the recalled products were primarily distributed to hospitals and some physicians’ offices, distributors and retailers in the United States. and in Puerto Rico.
According to the announcement, production of Similac 2 fl oz / 59 milliliter ready-to-use liquid formula given to hospitals and other healthcare providers will continue on a different production line.
The recall does not include other brands of powdered or liquid formula produced in Installing Columbus or elsewhere.
Abbott’s executive vice president for nutritional products, Joe Manning, said the company is tackling the problem and minimizing inconvenience to customers.
“We take our responsibility to provide high quality products very seriously,” Manning said. “We have identified the problem internally, are resolving it and will work with our customers to minimize the inconvenience and provide them with the products they need.”